hiPSC‐CMs from DMD patients exhibit dystrophin loss, abnormal calcium handling, mitochondrial damage, increased ROS, dysregulated iron metabolism and altered electrophysiology [62, 63, 64], supporting their use in preclinical therapy testing. Here, DMD is linked to Duchenne muscular dystrophy.